Description

Summary data or treatment comparison from the comprehensive review of androgenetic alopecia therapies, covering minoxidil, finasteride, dutasteride, LLLT, PRP, and emerging treatments.

Figure 4

Source Paper

Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs.

Clinical, cosmetic and investigational dermatology (2023)

PMID: 37284568

DOI: 10.2147/CCID.S385861

Cite This Figure

![Figure 4: Summary data or treatment comparison from the comprehensive review of androgenetic alopecia therapies, covering minoxidil, finasteride, dutasteride, LLLT, PRP, and emerging treatments.]()

> Source: Michael Kaiser et al. "Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs.." *Clinical, cosmetic and investigational dermatology*, 2023. PMID: [37284568](https://pubmed.ncbi.nlm.nih.gov/37284568/)

<figure>
  <img src="" alt="Summary data or treatment comparison from the comprehensive review of androgenetic alopecia therapies, covering minoxidil, finasteride, dutasteride, LLLT, PRP, and emerging treatments." />
  <figcaption>Figure 4. Summary data or treatment comparison from the comprehensive review of androgenetic alopecia therapies, covering minoxidil, finasteride, dutasteride, LLLT, PRP, and emerging treatments.<br>  Source: Michael Kaiser et al. "Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs.." <em>Clinical, cosmetic and investigational dermatology</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37284568/">37284568</a></figcaption>
</figure>

Preuves associées

Minoxidil pour Alopécie Androgénétique

Note A · 299 études

Finasteride pour Alopécie Androgénétique

Note A · 206 études

Thérapie laser de faible intensité pour Alopécie Androgénétique

Note A · 60 études

Micro-aiguilles pour Alopécie Androgénétique

Note A · 62 études

Thérapie PRP pour Alopécie Androgénétique

Note A · 144 études

Spironolactone pour Alopécie Androgénétique

Note A · 45 études